CUE / Cue Biopharma, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Cue Biopharma, Inc.
US ˙ NasdaqCM ˙ US22978P1066

Jumlah Saham Beredar 76,845,904 shares
Saham Orang Dalam4,058,136 shares
Kepemilikan oleh Orang Dalam5.28 %
Orang Dalam Sejati23
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

0 ( )

1204 out of 11305

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

0.000 %( )

1203 out of 11224

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Cue Biopharma, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Rodolfo Chaparro EVP, Head of Immunology - [O] 890,000 890,000
Anthony Digiandomenico Director - [D] 30,000 30,000
Frederick W Driscoll Director - [D] 0 0
Fletcher Aaron G.L. Director - [D] 940,000 940,000
Michael J Fox Director - [D] 100,000 100,000
Cameron Gray Director - [D] 687,049 687,049
Tamar D Howson 10,000
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Peter A Kiener Director - [D] 357 357
Matteo Levisetti Chief Medical Officer - [O] 9,230 9,230
Christopher A Marlett Director - [D] 0 0
Steven L Mcknight 8,000
Bethany Mancilla SVP and Chief Business Officer - [O] 0 0
Kerri-Ann Millar CHIEF FINANCIAL OFFICER - [O] 14,311 14,311
Frank Morich Director - [D] 28,000 28,000
Patricia Nasshorn 10,000
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Daniel R Passeri CHIEF EXECUTIVE OFFICER, Director - [D] [O] 164,578 164,578
Kenneth Pienta Chief Medical Officer - [O] 2,000 2,000
Gary Alan Schuman Interim CFO - [O] 133,500 133,500
Colin Sandercock SVP, General Counsel and Sec - [O] 17,125 17,125
Seidel Ronald D. III EVP, Head of R&D - [O] 890,000 890,000
Simon Barry J. 10,000
Anish Suri PRESIDENT AND CSO - [O] 135,638 135,638
Patrick Verheyen Director - [D] 16,348 16,348

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di CUE / Cue Biopharma, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2024-12-16 PASSERI DANIEL R 30,000 1.0300 30,000 1.0300 30,900 21 1.7500 21,600 69.90
2023-08-25 Suri Anish 4,000 2.7600 4,000 2.7600 11,040
2023-08-14 PASSERI DANIEL R 3,000 2.8600 3,000 2.8600 8,580
2022-05-27 Morich Frank 28,000 3.7500 28,000 3.7500 105,000
2022-05-24 Fletcher Aaron G.L. 55,000 3.3400 55,000 3.3400 183,700
2022-05-23 Fletcher Aaron G.L. 150,000 3.5200 150,000 3.5200 528,000
2022-03-31 Fletcher Aaron G.L. 735,000 4.7600 735,000 4.7600 3,498,600
2021-09-24 PASSERI DANIEL R 3,400 14.7210 3,400 14.7210 50,051
2021-01-20 Pienta Kenneth 2,720 15.0660 2,720 15.0660 40,980

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

CUE / Cue Biopharma, Inc. Insider Trades
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di CUE / Cue Biopharma, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2023-03-23 Kiener Peter A 9,325 3.2800 9,325 3.2800 30,586 214 1.7200 -14,547 -47.56
2019-12-31 MARLETT CHRISTOPHER A 9,000 15.7100 9,000 15.7100 141,390
2019-12-31 MARLETT CHRISTOPHER A 6,700 15.7700 6,700 15.7700 105,659
2019-12-27 MARLETT CHRISTOPHER A 9,000 17.2400 9,000 17.2400 155,160
2019-12-26 MARLETT CHRISTOPHER A 19,647 17.5300 19,647 17.5300 344,412
2019-12-23 MARLETT CHRISTOPHER A 17,000 16.8200 17,000 16.8200 285,940
2019-12-19 MARLETT CHRISTOPHER A 4,000 17.0000 4,000 17.0000 68,000
2019-12-17 MARLETT CHRISTOPHER A 20,732 15.7300 20,732 15.7300 326,114

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

CUE / Cue Biopharma, Inc. Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas
Tanggal
Perdagangan
Tanggal
Formulir Orang Dalam Ticker Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Unit
Diubah
Nilai
Diubah (1 ribu)
Sisa
Pilihan
Sisa
Saham
2024-12-18 2024-12-16 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 1.0300 30,000 31 164,578
2024-06-07 3 Fox Michael J By MF Capital Partners, LLC CUE Common Stock I 100,000
2024-06-07 3 Fox Michael J By Park City Capital Offshore Master, Ltd. CUE Common Stock I 1,000,000
2023-08-29 2023-08-25 4 Suri Anish CUE Common Stock P - Purchase D 2.7600 4,000 11 135,638
2023-08-16 2023-08-14 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 2.8600 3,000 9 134,578
2023-04-13 3 Verheyen Patrick CUE Common Stock D 8,174
2023-03-27 2023-03-23 4 Kiener Peter A CUE Common Stock S - Sale D 3.2800 -9,325 -31 357
2023-03-27 2023-03-23 4 Kiener Peter A CUE Common Stock M - Exercise D 2.8600 9,682 28 9,682
2023-01-19 3 Levisetti Matteo CUE Common Stock D 9,230
2022-08-23 2022-08-22 4 Millar Kerri-Ann CUE Common Stock F - Taxes D 3.0500 -2,828 -9 14,311
2022-08-23 2022-08-21 4 Millar Kerri-Ann CUE Common Stock M - Exercise D 6,667 17,139
2022-06-16 2022-06-14 4 Gray Cameron CUE Common Stock F - Taxes D 3.2000 -51,562 -165 687,049
2022-06-16 2022-06-14 4 Gray Cameron CUE Common Stock X - Other D 2.7000 61,111 165 738,611
2022-05-31 2022-05-27 4 Morich Frank CUE Common Stock P - Purchase D 3.7500 28,000 105 28,000
2022-05-25 2022-05-24 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase I 3.3400 55,000 184 940,000
2022-05-25 2022-05-23 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase I 3.5200 150,000 528 885,000
2022-04-04 2022-03-31 4 Suri Anish CUE Restricted Stock Units M - Exercise D -16,668 0
2022-04-04 2022-03-31 4 Suri Anish CUE Common Stock F - Taxes D 4.8800 -7,068 -34 103,638
2022-04-04 2022-03-31 4 Suri Anish CUE Common Stock M - Exercise D 16,668 110,706
2022-04-04 2022-03-31 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase I 4.7600 735,000 3,499 735,000
2022-04-04 2022-03-31 4 PASSERI DANIEL R CUE Restricted Stock Units M - Exercise D -75,000 0
2022-04-04 2022-03-31 4 PASSERI DANIEL R CUE Common Stock G - Gift D -10,000 131,578
2022-04-04 2022-03-31 4 PASSERI DANIEL R CUE Common Stock F - Taxes D 4.8800 -32,122 -157 141,578
2022-04-04 2022-03-31 4 PASSERI DANIEL R CUE Common Stock M - Exercise D 75,000 173,700
2022-03-29 2022-03-25 4 NASSHORN PATRICIA CUE Stock Option (right to buy) A - Award D 5.01 10,000 10,000
2022-03-29 2022-03-25 4 Suri Anish CUE Stock Option (right to buy) A - Award D 5.01 21,333 21,333
2022-03-29 2022-02-09 4 Suri Anish CUE Stock Option (right to buy) A - Award D 6.91 82,000 82,000
2022-03-29 2022-03-25 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 5.01 16,667 16,667
2022-03-29 2022-02-09 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 6.91 60,000 60,000
2022-03-29 2022-03-25 4 Pienta Kenneth CUE Stock Option (right to buy) A - Award D 5.01 40,000 40,000
2022-03-29 2022-03-25 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 5.01 100,000 100,000
2022-03-29 2022-03-25 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 5.01 10,000 10,000
2022-03-29 2022-02-09 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 6.91 85,000 85,000
2022-01-05 2022-01-03 4 Fletcher Aaron G.L. CUE Stock Option (right to buy) A - Award D 12.28 10,000 10,000
2022-01-05 2022-01-03 4 Kiener Peter A CUE Stock Option (right to buy) A - Award D 12.28 10,000 10,000
2022-01-05 2022-01-03 4 Morich Frank CUE Stock Option (right to buy) A - Award D 12.28 10,000 10,000
2022-01-05 2022-01-03 4 HOWSON TAMAR D CUE Stock Option (right to buy) A - Award D 12.28 10,000 10,000
2022-01-05 2022-01-03 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 12.28 10,000 10,000
2022-01-05 2022-01-03 4 Gray Cameron CUE Stock Option (right to buy) A - Award D 12.28 10,000 10,000
2022-01-04 2021-12-15 4 NASSHORN PATRICIA CUE Stock Option (right to buy) A - Award D 11.24 100,000 100,000
2021-12-21 2021-12-20 4 Pienta Kenneth CUE Stock Option (right to buy) A - Award D 11.45 80,000 80,000
2021-11-17 2021-11-16 4 Kiener Peter A CUE Stock Option (right to buy) M - Exercise D 2.86 -1,361 105,744
2021-11-17 2021-11-16 4 Kiener Peter A CUE Common Stock S - Sale D 18.0200 -1,361 -25 0
2021-11-17 2021-11-16 4 Kiener Peter A CUE Common Stock M - Exercise D 2.8600 1,361 4 1,361
2021-11-17 2021-11-15 4 Kiener Peter A CUE Stock Option (right to buy) M - Exercise D 2.86 -18,815 107,105
2021-11-17 2021-11-15 4 Kiener Peter A CUE Common Stock S - Sale D 17.9200 -18,815 -337 0
2021-11-17 2021-11-15 4 Kiener Peter A CUE Common Stock M - Exercise D 2.8600 18,815 54 18,815
2021-11-17 2021-11-15 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 8.26 -8,000 10,000
2021-11-17 2021-11-15 4 Suri Anish CUE Common Stock S - Sale D 18.0500 -8,000 -144 94,038
2021-11-17 2021-11-15 4 Suri Anish CUE Common Stock M - Exercise D 8.2600 8,000 66 102,038
2021-11-15 2021-11-11 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6.42 -20,000 105,000
2021-11-15 2021-11-11 4 Suri Anish CUE Common Stock S - Sale D 15.0677 -20,000 -301 94,038
2021-11-15 2021-11-11 4 Suri Anish CUE Common Stock M - Exercise D 6.4200 20,000 128 114,038
2021-10-08 2021-10-06 4 Suri Anish CUE Common Stock F - Taxes D 12.9700 -14,134 -183 94,038
2021-10-08 2021-10-03 4 Suri Anish CUE Restricted Stock Units M - Exercise D -33,334 0
2021-10-08 2021-10-03 4 Suri Anish CUE Common Stock M - Exercise D 33,334 108,172
2021-10-08 2021-09-30 4 PASSERI DANIEL R CUE Restricted Stock Units M - Exercise D -75,000 75,000
2021-10-08 2021-09-30 4 PASSERI DANIEL R CUE Common Stock F - Taxes D 14.5700 -31,677 -462 98,700
2021-10-08 2021-09-30 4 PASSERI DANIEL R CUE Common Stock M - Exercise D 75,000 130,377
2021-10-05 2021-10-01 4 Millar Kerri-Ann CUE Stock Option (right to buy) M - Exercise D 7.50 -1,251 53,749
2021-10-05 2021-10-01 4 Millar Kerri-Ann CUE Common Stock S - Sale D 14.2149 -1,251 -18 10,472
2021-10-05 2021-10-01 4 Millar Kerri-Ann CUE Common Stock M - Exercise D 7.5000 1,251 9 11,723
2021-10-05 2021-08-23 4 Millar Kerri-Ann CUE Restricted Stock Units M - Exercise D -6,667 6,667
2021-10-05 2021-08-23 4 Millar Kerri-Ann CUE Common Stock F - Taxes D -1,961 10,472
2021-10-05 2021-08-23 4 Millar Kerri-Ann CUE Common Stock M - Exercise D 6,667 12,433
2021-09-27 2021-09-24 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 14.7210 3,400 50 55,377
2021-09-27 2021-09-23 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6.42 -20,000 125,000
2021-09-27 2021-09-23 4 Suri Anish CUE Common Stock S - Sale D 15.2323 -20,000 -305 74,838
2021-09-27 2021-09-23 4 Suri Anish CUE Common Stock M - Exercise D 6.4200 20,000 128 94,838
2021-03-17 2021-03-16 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 5.00 -439 133,567
2021-03-17 2021-03-16 4 Pienta Kenneth CUE Common Stock S - Sale D 15.0926 -439 -7 2,000
2021-03-17 2021-03-16 4 Pienta Kenneth CUE Common Stock M - Exercise D 5.0000 439 2 2,439
2021-03-17 2021-03-15 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 5.00 -13,000 134,006
2021-03-17 2021-03-15 4 Pienta Kenneth CUE Common Stock S - Sale D 15.0976 -13,000 -196 2,000
2021-03-17 2021-03-15 4 Pienta Kenneth CUE Common Stock M - Exercise D 5.0000 13,000 65 15,000
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 5.00 -2,994 147,006
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 2.86 -1,280 0
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Common Stock S - Sale D 15.0550 -4,274 -64 2,000
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Common Stock M - Exercise D 5.0000 2,994 15 6,274
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Common Stock M - Exercise D 2.8600 1,280 4 3,280
2021-02-18 2021-02-16 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 2.86 -16,000 1,280
2021-02-18 2021-02-16 4 Pienta Kenneth CUE Common Stock S - Sale D 15.1514 -16,000 -242 2,000
2021-02-18 2021-02-16 4 Pienta Kenneth CUE Common Stock M - Exercise D 2.8600 16,000 46 18,000
2021-02-18 2021-01-20 4/A Pienta Kenneth CUE Common Stock S - Sale D 15.0660 -2,720 -41 2,000
2021-02-18 2021-01-20 4/A Pienta Kenneth CUE Common Stock M - Exercise D 2.8600 2,720 8 4,720
2021-02-12 2021-02-10 4 Pienta Kenneth CUE Stock Option (right to buy) A - Award D 15.55 50,000 50,000
2021-02-12 2021-02-10 4 Suri Anish CUE Stock Option (right to buy) A - Award D 15.55 75,000 75,000
2021-02-12 2021-02-10 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 15.55 85,000 85,000
2021-02-12 2021-02-10 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 15.55 70,000 70,000
2021-02-12 2021-02-10 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 15.55 50,000 50,000
2021-02-01 2020-12-02 5 Gray Cameron By Julie Heider Nongrantor Pot Trust under the Julie Heider 2020 Irrevocable Trust CUE Common Stock G - Gift I 271,000 271,000
2021-02-01 2020-12-02 5 Gray Cameron By Family Nongrantor Pot Trust under the Cameron Gray 2020 Irrevocable Trust CUE Common Stock G - Gift I 162,600 162,600
2021-02-01 2020-12-02 5 Gray Cameron By Extended Family Nongrantor Pot Trust under the Cameron Gray 2020 Irrevocable Trust CUE Common Stock G - Gift I 162,600 162,600
2021-02-01 2020-12-02 5 Gray Cameron CUE Common Stock G - Gift D -596,200 81,300
2021-01-22 2021-01-20 4 Pienta Kenneth CUE Common Stock P - Purchase D 15.0660 2,720 41 4,720
2021-01-06 2021-01-04 4 Simon Barry J. CUE Stock Option (right to buy) A - Award D 12.36 10,000 10,000
2021-01-06 2021-01-04 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 12.36 10,000 10,000
2021-01-06 2021-01-04 4 Kiener Peter A CUE Stock Option (right to buy) A - Award D 12.36 10,000 10,000
2021-01-06 2021-01-04 4 Morich Frank CUE Stock Option (right to buy) A - Award D 12.36 10,000 10,000
2021-01-06 2021-01-04 4 Fletcher Aaron G.L. CUE Stock Option (right to buy) A - Award D 12.36 10,000 10,000
2021-01-06 2021-01-04 4 Gray Cameron CUE Stock Option (right to buy) A - Award D 12.36 10,000 10,000
2021-01-06 2021-01-04 4 HOWSON TAMAR D CUE Stock Option (right to buy) A - Award D 12.36 10,000 10,000
2020-11-25 2020-11-24 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase D 12.6414 6,548 83 165,000
2020-10-06 2020-10-05 4 Suri Anish CUE Common Stock F - Taxes D 16.3000 -9,800 -160 58,091
2020-10-06 2020-10-03 4 Suri Anish CUE Restricted Stock Units M - Exercise D -33,333 33,334
2020-10-06 2020-10-03 4 Suri Anish CUE Common Stock M - Exercise D 33,333 67,891
2020-10-01 2020-09-30 4 Gray Cameron CUE Common Stock P - Purchase D 15.3000 5,000 76 677,500
2020-10-01 2020-09-29 4 Gray Cameron CUE Common Stock P - Purchase D 15.0000 5,000 75 672,500
2020-09-18 2020-09-17 4 HOWSON TAMAR D CUE Stock Option (right to buy) A - Award D 17.21 50,000 50,000
2020-08-25 2020-08-24 4 Millar Kerri-Ann CUE Common Stock F - Taxes D -1,900 5,766
2020-08-25 2020-08-21 4 Millar Kerri-Ann CUE Restricted Stock Units M - Exercise D -6,666 13,334
2020-08-25 2020-08-21 4 Millar Kerri-Ann CUE Restricted Stock Units A - Award D 20,000 20,000
2020-08-25 2020-08-21 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 19.87 65,000 65,000
2020-08-25 2020-08-21 4 Millar Kerri-Ann CUE Common Stock M - Exercise D 6,666 7,666
2020-08-10 2020-08-05 4/A Sandercock Colin CUE Stock Option (right to buy) M - Exercise D 7.50 -13,374 130,000
2020-08-10 2020-08-05 4/A Sandercock Colin CUE Common Stock S - Sale D 20.0000 -13,374 -267 17,125
2020-08-10 2020-08-05 4/A Sandercock Colin CUE Common Stock M - Exercise D 7.5000 13,374 100 30,499
2020-08-07 2020-08-05 4 Sandercock Colin CUE Stock Option (right to buy) M - Exercise D 7.50 -13,274 130,100
2020-08-07 2020-08-05 4 Sandercock Colin CUE Common Stock S - Sale D 20.0000 -13,274 -265 17,125
2020-08-07 2020-08-05 4 Sandercock Colin CUE Common Stock M - Exercise D 7.5000 13,274 100 30,399
2020-08-07 2020-08-05 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6.42 -800 145,000
2020-08-07 2020-08-05 4 Suri Anish CUE Common Stock S - Sale D 20.0100 -800 -16 34,558
2020-08-07 2020-08-05 4 Suri Anish CUE Common Stock M - Exercise D 6.4200 800 5 35,358
2020-08-05 2020-08-04 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6.42 -400 145,800
2020-08-05 2020-08-04 4 Suri Anish CUE Common Stock S - Sale D 20.1400 -400 -8 34,558
2020-08-05 2020-08-04 4 Suri Anish CUE Common Stock M - Exercise D 6.4200 400 3 34,958
2020-08-05 2020-08-03 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6.42 -3,800 146,200
2020-08-05 2020-08-03 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 8.26 -2,000 18,000
2020-08-05 2020-08-03 4 Suri Anish CUE Common Stock S - Sale D 20.0100 -5,800 -116 34,558
2020-08-05 2020-08-03 4 Suri Anish CUE Common Stock M - Exercise D 6.4200 3,800 24 40,358
2020-08-05 2020-08-03 4 Suri Anish CUE Common Stock M - Exercise D 8.2600 2,000 17 36,558
2020-08-05 2020-08-04 4 Sandercock Colin CUE Stock Option (right to buy) M - Exercise D 7.50 -201 143,374
2020-08-05 2020-08-04 4 Sandercock Colin CUE Common Stock S - Sale D 20.0500 -201 -4 17,125
2020-08-05 2020-08-04 4 Sandercock Colin CUE Common Stock M - Exercise D 7.5000 201 2 17,326
2020-08-05 2020-08-03 4 Sandercock Colin CUE Stock Option (right to buy) M - Exercise D 7.50 -6,425 143,575
2020-08-05 2020-08-03 4 Sandercock Colin CUE Common Stock S - Sale D 20.0000 -6,425 -128 17,125
2020-08-05 2020-08-03 4 Sandercock Colin CUE Common Stock M - Exercise D 7.5000 6,425 48 23,550
2020-06-25 2020-06-24 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase D 25.2400 2,953 75 158,452
2020-06-25 2020-06-24 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase D 24.6400 4,547 112 155,499
2020-05-12 2020-05-11 4 Morich Frank CUE Stock Option (right to buy) A - Award D 27.56 1,200 1,200
2020-04-10 2020-03-31 4 Suri Anish CUE Restricted Stock Units M - Exercise D -16,666 100,001
2020-04-10 2020-03-31 4 Suri Anish CUE Restricted Stock Units A - Award D 50,000 116,667
2020-04-10 2020-03-31 4 Suri Anish CUE Common Stock F - Taxes D -5,354 34,558
2020-04-10 2020-03-31 4 Suri Anish CUE Common Stock M - Exercise D 16,666 39,912
2020-03-26 2020-03-24 4 Pienta Kenneth CUE Stock Option (right to buy) A - Award D 14.00 100,000 100,000
2020-02-24 2019-06-10 4/A Sandercock Colin CUE Common Stock P - Purchase D 7.9000 15,025 119 17,125
2020-02-24 2019-06-07 4/A Sandercock Colin CUE Common Stock P - Purchase D 7.3500 100 1 2,100
2020-02-12 2020-02-05 4 PASSERI DANIEL R CUE Restricted Stock Units A - Award D 150,000 150,000
2020-02-12 2020-02-05 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 16.26 150,000 150,000
2020-02-12 2020-02-05 4 Suri Anish CUE Stock Option (right to buy) A - Award D 16.26 65,000 65,000
2020-02-12 2020-02-05 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 16.26 30,000 30,000
2020-02-12 2020-02-05 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 16.26 20,000 20,000
2020-01-06 2020-01-02 4 Morich Frank CUE Stock Option (right to buy) A - Award D 16.31 8,000 8,000
2020-01-06 2020-01-02 4 Simon Barry J. CUE Stock Option (right to buy) A - Award D 16.31 9,600 9,600
2020-01-06 2020-01-02 4 Fletcher Aaron G.L. CUE Stock Option (right to buy) A - Award D 16.31 8,000 8,000
2020-01-06 2020-01-02 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 16.31 8,000 8,000
2020-01-06 2020-01-02 4 Gray Cameron CUE Stock Option (right to buy) A - Award D 16.31 8,000 8,000
2020-01-06 2020-01-02 4 Kiener Peter A CUE Stock Option (right to buy) A - Award D 16.31 8,000 8,000
2020-01-06 2020-01-02 4 MARLETT CHRISTOPHER A CUE Stock Option (right to buy) A - Award D 16.31 8,000 8,000
2020-01-06 2020-01-02 4 MCKNIGHT STEVEN L CUE Stock Option (right to buy) A - Award D 16.31 8,000 8,000
2019-12-31 2019-12-31 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale D 15.7100 -9,000 -141 0
2019-12-31 2019-12-31 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 15.7700 -6,700 -106 768,503
2019-12-31 2019-12-27 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 17.2400 -9,000 -155 775,203
2019-12-27 2019-12-26 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 17.5300 -19,647 -344 784,203
2019-12-27 2019-12-23 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 16.8200 -17,000 -286 803,850
2019-12-19 2019-12-19 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 17.0000 -4,000 -68 820,850
2019-12-19 2019-12-17 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 15.7300 -20,732 -326 824,850
2019-12-19 2019-12-12 4 MARLETT CHRISTOPHER A CUE Common Stock J - Other I 755,980 845,582
2019-12-19 2019-12-12 4 MARLETT CHRISTOPHER A CUE Common Stock J - Other I -1,007,973 0
2019-11-04 2019-11-01 4 Suri Anish CUE Restricted Stock Units M - Exercise D -33,333 66,667
2019-11-04 2019-11-01 4 Suri Anish CUE Common Stock F - Taxes D 8.6300 -12,087 -104 23,246
2019-11-04 2019-11-01 4 Suri Anish CUE Common Stock M - Exercise D 33,333 35,333
2019-10-07 2019-10-03 4 Suri Anish CUE Restricted Stock Units A - Award D 100,000 0
2019-10-07 2019-10-03 4 Suri Anish CUE Stock Option (right to buy) A - Award D 7.53 7.5300 400,000 3,012 400,000
2019-10-07 3 Fletcher Aaron G.L. CUE Common Stock D 310,771
2019-10-07 3 Fletcher Aaron G.L. CUE Common Stock D 310,771
2019-10-07 3 Fletcher Aaron G.L. By spouse CUE Common Stock I 168,686
2019-10-07 3 Fletcher Aaron G.L. By spouse CUE Common Stock I 168,686
2019-10-07 3 Fletcher Aaron G.L. CUE Common Stock D 310,771
2019-10-07 3 Fletcher Aaron G.L. By spouse CUE Common Stock I 168,686
2019-10-07 2019-10-03 4 Fletcher Aaron G.L. CUE Stock Option (right to buy) A - Award D 7.53 50,000 50,000
2019-06-25 2019-06-21 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 7.2600 1,377 10 51,977
2019-06-10 2019-06-10 4 Sandercock Colin CUE Common Stock P - Purchase D 7.9300 14,938 118 16,938
2019-06-10 2019-06-06 4 Sandercock Colin CUE Common Stock P - Purchase D 7.1000 2,000 14 2,000
2019-06-07 2019-06-06 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 6.9000 3,000 21 50,600
2019-03-08 2019-03-06 4 Mancilla Bethany CUE Stock Option (right to buy) A - Award D 9.54 100,000 100,000
2019-03-08 2019-03-06 4 Mancilla Bethany CUE Stock Option (right to buy) A - Award D 6.42 65,000 65,000
2019-03-08 2019-03-06 4 Suri Anish CUE Stock Option (right to buy) A - Award D 11.54 100,000 100,000
2019-03-08 2019-03-06 4 Suri Anish CUE Stock Option (right to buy) A - Award D 6.42 150,000 150,000
2019-03-08 2019-03-06 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 11.54 100,000 100,000
2019-03-08 2019-03-06 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 6.42 125,000 125,000
2019-03-08 2019-03-06 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 6.42 30,000 30,000
2019-03-08 2019-03-06 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 7.50 100,000 100,000
2019-03-08 2019-03-06 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 6.42 50,000 50,000
2019-01-28 2017-12-29 4 Gray Cameron CUE Warrants J - Other D 9.38 192,495 192,495
2019-01-28 2017-12-29 4 MARLETT CHRISTOPHER A CUE Warrants J - Other I 9.38 -416,656 416,656
2019-01-15 2018-07-10 5 MARLETT CHRISTOPHER A CUE Common Stock G - Gift I -9,000 1,007,973
2019-01-15 2018-04-05 5 MARLETT CHRISTOPHER A CUE Common Stock G - Gift I -1,000 1,016,973
2019-01-04 2018-12-24 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 4.8100 10,000 48 30,000
2019-01-03 2019-01-02 4 DIGIANDOMENICO ANTHONY CUE Stock Option (right to buy) A - Award D 5.16 8,000 8,000
2019-01-03 2019-01-02 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 5.16 8,000 8,000
2019-01-03 2019-01-02 4 Gray Cameron CUE Stock Option (right to buy) A - Award D 5.16 8,000 8,000
2019-01-03 2019-01-02 4 Kiener Peter A CUE Stock Option (right to buy) A - Award D 5.16 8,000 8,000
2019-01-03 2019-01-02 4 MARLETT CHRISTOPHER A CUE Stock Option (right to buy) A - Award D 5.16 8,000 8,000
2019-01-03 2019-01-02 4 MCKNIGHT STEVEN L CUE Stock Option (right to buy) A - Award D 5.16 8,000 8,000
2019-01-03 2019-01-02 4 Morich Frank CUE Stock Option (right to buy) A - Award D 5.16 8,000 8,000
2019-01-03 2019-01-02 4 Simon Barry J. CUE Stock Option (right to buy) A - Award D 5.16 9,600 9,600
2019-01-02 2018-12-28 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 4.6200 7,000 32 57,000
2019-01-02 2018-12-31 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4.6400 18,521 86 89,602
2018-12-28 2018-12-27 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 4.7700 20,000 95 50,000
2018-12-27 2018-12-26 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4.2900 19,647 84 71,081
2018-12-26 2018-12-21 4 Suri Anish CUE Common Stock P - Purchase D 4.3700 2,000 9 2,000
2018-12-26 2018-12-21 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 4.4900 10,000 45 20,000
2018-12-26 2018-12-21 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4.5300 17,200 78 51,434
2018-12-21 2018-12-20 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4.7400 9,438 45 34,234
2018-12-20 2018-12-19 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 5.0000 400 2 24,796
2018-12-19 2018-12-18 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 5.2000 3,664 19 24,396
2018-12-18 2018-12-17 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 5.4800 10,000 55 10,000
2018-12-17 2018-12-13 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 5.0600 10,000 51 20,732
2018-12-13 2018-12-12 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 5.0700 3,189 16 10,732
2018-12-13 2018-12-12 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase D 5.0900 9,000 46 9,000
2018-12-12 2018-12-11 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4.8600 7,543 37 7,543
2018-08-29 2018-08-29 4 Millar Kerri-Ann CUE Common Stock P - Purchase D 8.4800 1,000 8 1,000
2018-08-20 2018-08-16 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 8.0850 6,000 49 47,600
2018-08-16 2018-08-14 4 Suri Anish CUE Stock Option (right to buy) A - Award D 8.26 20,000 20,000
2018-08-02 3 Morich Frank CUE No securities are beneficially owned D 0
2018-08-02 2018-07-31 4 Morich Frank CUE Stock Option (right to buy) A - Award D 9.06 50,000 50,000
2018-08-02 3 Mancilla Bethany CUE No securities are beneficially owned D 0
2018-08-02 2018-08-01 4 Mancilla Bethany CUE Stock Option (right to buy) A - Award D 9.54 250,000 250,000
2018-07-25 2018-07-23 4 Chaparro Rodolfo CUE Stock Option (right to buy) A - Award D 11.54 75,000 75,000
2018-07-25 2018-07-23 4 Seidel Ronald D. III CUE Stock Option (right to buy) A - Award D 11.54 75,000 75,000
2018-07-25 2018-07-23 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 11.54 50,000 50,000
2018-06-29 2018-06-29 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 11.9700 1,600 19 41,600
2018-06-27 2018-06-26 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 12.97 50,000 50,000
2018-06-27 3 DRISCOLL FREDERICK W CUE No securities are beneficially owned D 0
2018-06-14 2018-06-12 4 Gray Cameron CUE Stock Option (right to buy) M - Exercise D 14.24 8,000 8,000
2018-06-14 2018-06-12 4 MCKNIGHT STEVEN L CUE Stock Option (right to buy) M - Exercise D 14.24 8,000 8,000
2018-06-14 2018-06-12 4 Simon Barry J. CUE Stock Option (Right to Buy) M - Exercise D 14.24 8,000 8,000
2018-06-14 2018-06-12 4 MARLETT CHRISTOPHER A CUE Stock Option (right to buy) M - Exercise D 14.24 8,000 8,000
2018-06-14 2018-06-12 4 Kiener Peter A CUE Stock Option (right to buy) M - Exercise D 14.24 9,600 9,600
2018-06-14 2018-06-12 4 DIGIANDOMENICO ANTHONY CUE Stock Option (right to buy) M - Exercise D 14.24 8,000 8,000
2018-05-16 3 Suri Anish CUE No securities are beneficially owned D 0
2018-05-16 2018-05-14 4 Suri Anish CUE Stock Options A - Award D 14.32 250,000 250,000
2018-01-19 2017-12-27 4 Pienta Kenneth CUE Common Stock P - Purchase D 7.5000 2,000 15 2,000
2017-12-29 2017-12-27 4 MARLETT CHRISTOPHER A CUE Warrants A - Award I 9.38 833,312 833,312
2017-12-27 3 Chaparro Rodolfo CUE Common Stock D 890,000
2017-12-27 3 Chaparro Rodolfo CUE Common Stock D 890,000
2017-12-27 3 DIGIANDOMENICO ANTHONY CUE No securities are beneficially owned D 0
2017-12-27 3 Gray Cameron CUE Common Stock D 1,335,000
2017-12-27 3 Gray Cameron CUE Common Stock D 1,335,000
2017-12-27 3 PASSERI DANIEL R CUE Common Stock D 80,000
2017-12-27 3 PASSERI DANIEL R CUE Common Stock D 80,000
2017-12-27 3 Sandercock Colin CUE No securities are beneficially owned D 0
2017-12-27 3 SCHUMAN GARY ALAN CUE Common Stock D 133,500
2017-12-27 3 SCHUMAN GARY ALAN CUE Common Stock D 133,500
2017-12-27 3 Seidel Ronald D. III CUE Common Stock D 890,000
2017-12-27 3 Seidel Ronald D. III CUE Common Stock D 890,000
2017-12-27 3 MARLETT CHRISTOPHER A CUE Common Stock I 2,035,946
2017-12-27 3 MARLETT CHRISTOPHER A CUE Common Stock I 2,035,946
2017-12-27 2017-12-27 4 Sandercock Colin CUE Stock Options A - Award D 7.50 150,000 150,000
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
Other Listings
DE:1UC € 0.66
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista